0001209191-18-064099.txt : 20181226 0001209191-18-064099.hdr.sgml : 20181226 20181226163540 ACCESSION NUMBER: 0001209191-18-064099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181221 FILED AS OF DATE: 20181226 DATE AS OF CHANGE: 20181226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vertex Pharmaceuticals (Europe) Ltd CENTRAL INDEX KEY: 0001761216 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 181252953 BUSINESS ADDRESS: STREET 1: 2 KINGDOM STREET, 9TH FLOOR CITY: LONDON STATE: X0 ZIP: W2 6BD BUSINESS PHONE: 617-341-6100 MAIL ADDRESS: STREET 1: 2 KINGDOM STREET, 9TH FLOOR CITY: LONDON STATE: X0 ZIP: W2 6BD REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 181252954 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-21 0 0001674416 CRISPR Therapeutics AG CRSP 0001761216 Vertex Pharmaceuticals (Europe) Ltd 2 KINGDOM ST., 9TH FLOOR LONDON X0 W2 6BD UNITED KINGDOM 0 0 1 0 0000875320 VERTEX PHARMACEUTICALS INC / MA 50 NORTHERN AVENUE BOSTON MA 02210 0 0 1 0 Common Shares 2018-12-21 4 P 0 22742 22.5784 A 5272742 D Common Shares 2018-12-24 4 P 0 2603 22.9147 A 5275345 D Common Shares 2018-12-24 4 P 0 11742 23.1766 A 5287087 D Common Shares 2018-12-24 4 P 0 53655 24.9687 A 5340742 D Shares are directly held by Vertex Pharmaceuticals (Europe) Limited ("Vertex Europe"). Vertex Europe is an indirect wholly owned subsidiary of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. may be deemed to beneficially own the shares owned directly by Vertex Europe. Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.46 and $22.70. Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.69 and $23.00. Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.02 and $23.25. Represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.82 and $25.00. /s/ Ian F. Smith, on behalf of Vertex Pharmaceuticals (Europe) Limited 2018-12-26 /s/ Ian F. Smith, on behalf of Vertex Pharmaceuticals Inc. 2018-12-26